Abstract:Several studies have reported a suppressed immune function (e.g. blast transformation) during depression. In an attempt to define the cellular basis of the reported immune disorders, the present study investigates the leukocyte cell subset profile of minor, simple major, and melancholic depressives, versus normal controls. We have counted the number of white blood cells (WBC) lymphocytes, monocytes, and granulocytes, while the number of lymphocyte (sub)populations has been identified by phenotype, using monoclonal antibody staining in conjunction with flow cytometry. The following cell surface antigens were determined: CD3+ (pan T), CD19+ (pan B), CD4+ (T helper/inducer), CD8+ (T suppressor/cytotoxic), CD4+CD45RA (T-memory cells), CD4+CD45RA+ (T-virgin cells), surface Ig, class II MHC HLA-DR, and CD25+ (IL-2 receptor). By means of pattern recognition methods, we established distinct immunological changes in minor and simple major depressed and in melancholic patients, setting them apart from the reference population. Depression, per se, is characterized by a higher number of WBC, monocytes, class II MHC HLA-DR, and memory T cells. Minor and simple major depressives exhibited an increased T helper/suppressor ratio. Increased numbers of IL-2 receptor bearing cells are a hallmark for major depression. Melancholics showed an increased number of pan T, pan B and T suppressor/cytotoxic cells. It was concluded that the established immune cell profile of depressed patients may point towards the existence of a systemic immune activation during that illness.

Depression‐related Disturbances in Mitogen‐induced Lymphocyte Responses and Interleukin‐1β and Soluble Interleukin‐2 Receptor Production

Impaired mitogen-induced lymphocyte responses and the hypothalamic-pituitary-adrenal axis in depressive disorders

Impaired Lymphocyte Stimulation by Mitogens in Severely Depressed Patients

Immune Disturbances in Severely Depressed Patients: Relationship with Cortisol Secretion.

A Further Exploration of the Relationships Between Immune Parameters and the Hpa-Axis Activity in Depressed-Patients

Immune Cell Parameters in Severely Depressed Patients: Negative Findings

Immune Disturbances During Major Depression: Upregulated Expression of Interleukin-2 Receptors

Increased Serum Soluble CD8 or Suppressor/cytotoxic Antigen Concentrations in Depression: Suppressive Effects of Glucocorticoids

Decreased serum dipeptidyl peptidase IV activity in major depression.

Relationships Between Interleukin-6 Activity, Acute Phase Proteins, and Function of the Hypothalamic-Pituitary-adrenal Axis in Severe Depression.

Suppressant effects of dexamethasone on the availability of plasma L-tryptophan and tyrosine in healthy controls and in depressed patients.

Mitogen-stimulated cell proliferation and cytokine production in major depressive disorder patients

Interleukin-1-Beta - A Putative Mediator of Hpa Axis Hyperactivity in Major Depression

Plasma Soluble Interleukin-2-receptor in Depression: Relationships to Plasma Neopterin and Serum IL-2 Concentrations and HPA-axis Activity

Increased Plasma Concentrations of Interleukin-6, Soluble Interleukin-6, Soluble Interleukin-2 and Transferrin Receptor in Major Depression.

Immunoendocrine aspects of major depression. Relationships between plasma interleukin-6 and soluble interleukin-2 receptor, prolactin and cortisol.

Increased Neopterin and Interferon-Gamma Secretion and Lower Availability of L-tryptophan in Major Depression: Further Evidence for an Immune Response

A Study on the Blunted Natural Killer Cell Activity in Severely Depressed Patients

Increased Mitogen-Induced Lymphocyte Proliferation in Treatment Resistant Depression: a Preliminary Study.

Increased Serum IL-6 and IL-1 Receptor Antagonist Concentrations in Major Depression and Treatment Resistant Depression.

Evidence for a Systemic Immune Activation During Depression: Results of Leukocyte Enumeration by Flow Cytometry in Conjunction with Monoclonal Antibody Staining